Modern approaches to cardiovascular amyloidosis treatment
Cardiovascular (cardiac) amyloidosis (CA) is a clinical pathology, usually of a geneticallymediated nature, initiated by the precipitation process of the insoluble fibrous protein with β-pleated sheet secondary structure. Such anomalous changes lead to the formation of amyloid fibrils, which may giv...
Saved in:
| Main Authors: | Svetlana N. Morozkina, Petr P. Snetkov, Roman O. Olekhnovich, Mayya V. Uspenskaya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Limited liability company «Science and Innovations» (Saratov)
2021-12-01
|
| Series: | Russian Open Medical Journal |
| Subjects: | |
| Online Access: | https://romj.org/node/417 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of diflunisal therapy in patients with transthyretin cardiac amyloidosis (ATTR-CA): a systematic review and meta-analysis
by: Wilbert Huang, et al.
Published: (2025-03-01) -
Outcomes in Cardiac Transthyretin Amyloidosis and Association With New York Heart Association Class: Real‐World Data
by: Maximilian Leo Müller, et al.
Published: (2024-07-01) -
Delays in diagnosis and treatment of ATTR cardiac amyloidosis: A real‐world data analysis
by: Julia Vogel, et al.
Published: (2025-08-01) -
A new era in treatment of cardiac amyloidosis: an overview of the Congress of cardiology
by: I. E. Strelkova
Published: (2022-01-01) -
Real‐world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study
by: Richard J. Nies, et al.
Published: (2025-04-01)